Option Care Health (NASDAQ:OPCH) Given New $38.00 Price Target at Barrington Research

Option Care Health (NASDAQ:OPCH) had its price objective lifted by equities researchers at Barrington Research from $33.00 to $38.00 in a report released on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s price objective points to a potential upside of 14.63% from the stock’s current price.

Several other research analysts also recently issued reports on OPCH. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, JPMorgan Chase & Co. lifted their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average target price of $32.88.

Option Care Health Price Performance

Option Care Health stock opened at $33.15 on Thursday. Option Care Health has a one year low of $21.39 and a one year high of $34.17. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business has a fifty day moving average of $28.28 and a two-hundred day moving average of $28.04. The company has a market cap of $5.64 billion, a P/E ratio of 27.86, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP grew its holdings in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after buying an additional 8,400,208 shares during the period. FMR LLC grew its holdings in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after buying an additional 4,304,896 shares during the period. Norges Bank purchased a new stake in Option Care Health in the 4th quarter valued at about $60,219,000. Victory Capital Management Inc. grew its holdings in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares during the period. Finally, Voloridge Investment Management LLC purchased a new stake in Option Care Health in the 4th quarter valued at about $27,428,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.